NEWLIMIT
Summary
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£32M
Avg. Deal Size£32M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
